Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, $0.000001 par value
-
Shares outstanding
-
14.3M
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
13.8M
-
Shares change
-
+428K
-
Total reported value, excl. options
-
$581M
-
Value change
-
+$18M
-
Number of buys
-
40
-
Number of sells
-
-24
-
Price
-
$41.96
Significant Holders of Neurogene Inc. - Common Stock, $0.000001 par value (NGNE) as of Q3 2024
87 filings reported holding NGNE - Neurogene Inc. - Common Stock, $0.000001 par value as of Q3 2024.
Neurogene Inc. - Common Stock, $0.000001 par value (NGNE) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.8M shares
of 14.3M outstanding shares and own 97.09% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (1.37M shares), EcoR1 Capital, LLC (1.27M shares), Samsara BioCapital, LLC (1.27M shares), RTW INVESTMENTS, LP (1.14M shares), GREAT POINT PARTNERS LLC (1M shares), Redmile Group, LLC (964K shares), FMR LLC (732K shares), JANUS HENDERSON GROUP PLC (709K shares), VANGUARD GROUP INC (576K shares), and Casdin Capital, LLC (525K shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.